Meningeal inflammation is widespread and linked to cortical pathology in multiple sclerosis

Brain

Volumn 134, Issue 9, 2011, Pages 2755-2771

  Howell, Owain W ^a   Reeves, Cheryl A ^a   Nicholas, Richard ^a   Carassiti, Daniele ^a   Radotra, Bishan ^a   Gentleman, Steve M ^a   Serafini, Barbara ^b   Aloisi, Francesca ^b   Roncaroli, Federico ^a   Magliozzi, Roberta ^b   Reynolds, Richard ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

B cell follicle; clinical disability; grey matter lesion; microglia; neuropathology

Indexed keywords

CD20 ANTIGEN; CD68 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; KI 67 ANTIGEN;

ADULT; AGED; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL STRUCTURE; CINGULATE SULCUS; CONTROLLED STUDY; DEMYELINATION; DENDRITIC CELL; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOREBRAIN; FRONTAL CORTEX; GRAY MATTER; HUMAN; HUMAN TISSUE; INFLAMMATORY INFILTRATE; INSULA; LATERAL BRAIN VENTRICLE; LYMPHOCYTIC INFILTRATION; MACROPHAGE; MALE; MENINGITIS; MICROGLIA; MULTIPLE SCLEROSIS; ONSET AGE; PLASMA CELL; PRIORITY JOURNAL; RELAPSE; SECONDARY PROGRESSIVE MULTIPLE SCLEROSIS; SEX DIFFERENCE; T LYMPHOCYTE; TEMPORAL CORTEX; WHITE MATTER;

EID: 80052927697     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awr182     Document Type: Article

References (70)

1. Aloisi F, Pujol-Borrell R. Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 2006; 6: 205-17. (Pubitemid 43290990)
2. Aloisi F, Serafini B, Magliozzi R, Howell OW, Reynolds R. Detection of Epstein-Barr virus and B-cell follicles in the multiple sclerosis brain: what you find depends on how and where you look. Brain 2010; 133: e157.
3. Armengol MP, Juan M, Lucas-Martin A, Fernandez-Figueras MT, Jaraquemada D, Gallart T, et al. Thyroid autoimmune disease: demonstration of thyroid antigen-specific B cells and recombination-activating gene expression in chemokine-containing active intrathyroidal germinal centers. Am J Pathol 2001; 159: 861-73. (Pubitemid 32847177)
4. Ascherio A, Munger KL. Environmental risk factors for multiple sclerosis. Part I: the role of infection. Ann Neurol 2007; 61: 288-99. (Pubitemid 46676728)
5. Bartholomaus I, Kawakami N, Odoardi F, Schlager C, Miljkovic D, Ellwart JW, et al. Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions. Nature 2009; 462: 94-8.
6. Bo L, Vedeler CA, Nyland H, Trapp BD, Mork SJ. Intracortical multiple sclerosis lesions are not associated with increased lymphocyte infiltration. Mult Scler 2003a; 9: 323-31. (Pubitemid 36958014)
7. Bo L, Vedeler CA, Nyland HI, Trapp BD, Mork SJ. Subpial demyelination in the cerebral cortex of multiple sclerosis patients. J Neuropathol. Exp. Neurol 2003b; 62: 723-32. (Pubitemid 36870458)
8. Brown DA, Sawchenko PE. Time course and distribution of inflammatory and neurodegenerative events suggest structural bases for the patho-genesis of experimental autoimmune encephalomyelitis. J Comp Neurol 2007; 502: 236-60. (Pubitemid 46595397)
9. Brink BP, Veerhuis R, Breij EC, van der Valk P, Dijkstra CD, Bo L. The pathology of multiple sclerosis is location-dependent: no significant complement activation is detected in purely cortical lesions. J Neuropathol Exp Neurol 2005; 64: 147-55. (Pubitemid 40349313)
10. Calabrese M, Filippi M, Gallo P. Cortical lesions in multiple sclerosis. Nat Rev Neurol 2010a; 6: 438-44.
11. Calabrese M, Rinaldi F, Mattisi I, Grossi P, Favaretto A, Atzori M, et al. Widespread cortical thinning characterizes patients with MS with mild cognitive impairment. Neurology 2010b; 74: 321-8.
12. Carragher DM, Rangel-Moreno J, Randall TD. Ectopic lymphoid tissues and local immunity. Semin Immunol 2008; 20: 26-42.
13. Chard DT, Griffin CM, McLean MA, Kapeller P, Kapoor R, Thompson AJ, et al. Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing-remitting multiple sclerosis. Brain 2002; 125: 2342-52.
14. Colombo M, Dono M, Gazzola P, Roncella S, Valetto A, Chiorazzi N, et al. Accumulation of clonally related B lymphocytes in the cerebro-spinal fluid of multiple sclerosis patients. J Immunol 2000; 164: 2782-9. (Pubitemid 30115513)
15. Compston A, Coles A. Multiple sclerosis. Lancet 2008; 372: 1502-17.
16. Confavreux C, Vukusic S. Age at disability milestones in multiple sclerosis. Brain 2006a; 129: 595-605. (Pubitemid 43278222)
17. Confavreux C, Vukusic S. Natural history of multiple sclerosis: a unifying concept. Brain 2006b; 129: 606-16. (Pubitemid 43278223)
18. Corcione A, Casazza S, Ferretti E, Giunti D, Zappia E, Pistorio A, et al. Recapitulation of B cell differentiation in the central nervous system of patients with multiple sclerosis. Proc Natl Acad Sci USA 2004; 101: 11064-9. (Pubitemid 38989584)
19. Dal Bianco A, Bradl M, Frischer J, Kutzelnigg A, Jellinger K, Lassmann H. Multiple sclerosis and Alzheimer's disease. Ann Neurol 2008; 63: 174-83. (Pubitemid 351355296)
20. Dalton CM, Chard DT, Davies GR, Miszkiel KA, Altmann DR, Fernando K, et al. Early development of multiple sclerosis is associated with progressive grey matter atrophy in patients presenting with clinically isolated syndromes. Brain 2004; 127: 1101-7. (Pubitemid 38623045)
21. De Stefano N, Matthews PM, Filippi M, Agosta F, De Luca M, Bartolozzi ML, et al. Evidence of early cortical atrophy in MS: relevance to white matter changes and disability. Neurology 2003; 60: 1157-62. (Pubitemid 36418778)
22. Farrell RA, Antony D, Wall GR, Clark DA, Fisniku L, Swanton J, et al. Humoral immune response to EBV in multiple sclerosis is associated with disease activity on MRI. Neurology 2009; 73: 32-8.
23. Fisher E, Lee JC, Nakamura K, Rudick RA. Gray matter atrophy in multiple sclerosis: a longitudinal study. Ann Neurol 2008; 64: 255-65.
24. Fisniku LK, Chard DT, Jackson JS, Anderson VM, Altmann DR, Miszkiel KA, et al. Gray matter atrophy is related to long-term disability in multiple sclerosis. Ann Neurol 2008; 64: 247-54.
25. Frischer JM, Bramow S, Dal-Bianco A, Lucchinetti CF, Rauschka H, Schmidbauer M, et al. The relation between inflammation and neurodegeneration in multiple sclerosis brains. Brain 2009; 132: 1175-89.
26. Gardner C, Rundle J, Patel R, Taylor D, Reynolds R. Subpial cortical demyelination induced by subarachnoid injection of tumour necrosis factor and IFN-gamma in MOG immunised animals. In: 25th Congress of the European-Committee-for-Treatment-and-Research-in-Multiple-Sclerosis, Sage Publications Ltd, 2009; 15: S182-S182.
27. Gray E, Thomas TL, Betmouni S, Scolding N, Love S. Elevated activity and microglial expression of myeloperoxidase in demyelinated cerebral cortex in multiple sclerosis. Brain Pathol 2008; 18: 86-95.
28. Guseo A, Jellinger K. The significance of perivascular infiltrations in multiple sclerosis. J Neurol 1975; 211: 51-60.
29. Hassin GB. Multiple sclerosis [disseminated sclerosis]: an investigation by the Association for research in nervous and mental disease. Vol. II. New York. P. B Hoeber, 1921.
30. Howell OW, Rundle JL, Garg A, Komada M, Brophy PJ, Reynolds R. Activated microglia mediate axoglial disruption that contributes to axonal injury in multiple sclerosis. J Neuropathol Exp Neurol 2010; 69: 1017-33.
31. Kidd D, Barkhof F, McConnell R, Algra PR, Allen IV, Revesz T. Cortical lesions in multiple sclerosis. Brain 1999; 122: 17-26. (Pubitemid 29046269)
32. Kivisakk P, Imitola J, Rasmussen S, Elyaman W, Zhu B, Ransohoff RM, et al. Localizing central nervous system immune surveillance: menin-geal antigen-presenting cells activate T cells during experimental autoimmune encephalomyelitis. Ann Neurol 2009; 65: 457-69.
33. Kooi EJ, Geurts JJ, van Horssen J, Bo L, van der Valk P. Meningeal inflammation is not associated with cortical demyelination in chronic multiple sclerosis. J Neuropathol Exp Neurol 2009; 68: 1021-8.
34. Kremenchutzky M, Rice GP, Baskerville J, Wingerchuk DM, Ebers GC. The natural history of multiple sclerosis: a geographically based study 9: observations on the progressive phase of the disease. Brain 2006; 129: 584-94. (Pubitemid 43278221)
35. Kutzelnigg A, Lucchinetti CF, Stadelmann C, Bruck W, Rauschka H, Bergmann M, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain 2005; 128: 2705-12. (Pubitemid 41552953)
36. Lassmann H, Bruck W, Lucchinetti CF. The immunopathology of multiple sclerosis: an overview. Brain Pathol 2007; 17: 210-8. (Pubitemid 46466140)
37. Lopes CA, Mair WG. Ultrastructure of the outer cortex and the pia mater in man. Acta Neuropathol 1974; 28: 79-86.
38. Lovato L, Willis SN, Rodig SJ, Caron T, Almendinger SE, Howell OW, et al. Related B cell clones populate the meninges and parenchyma of patients with multiple sclerosis. Brain 2011; 134: 534-41.
39. Lunemann JD, Tintore M, Messmer B, Strowig T, Rovira A, Perkal H, et al. Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis. Ann Neurol 2010; 67: 159-69.
40. Magalhaes R, Stiehl P, Morawietz L, Berek C, Krenn V. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Virchows Arch 2002; 441: 415-27. (Pubitemid 35430455)
41. Magliozzi R, Howell O, Vora A, Serafini B, Nicholas R, Puopolo M, et al. Meningeal B-cell follicles in secondary progressive multiple sclerosis associate with early onset of disease and severe cortical pathology. Brain 2007; 130: 1089-104. (Pubitemid 47355604)
42. Magliozzi R, Howell OW, Reeves C, Roncaroli F, Nicholas R, Serafini B, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol 2010; 68: 477-93.
43. Matsumoto Y, Abe S, Tsuchida M, Hirahara H, Abo T, Shin T, et al. Characterization of CD4-CD8-T cell receptor alpha beta + T cells appearing in the subarachnoid space of rats with autoimmune enceph-alomyelitis. Eur J Immunol 1996; 26: 1328-34. (Pubitemid 26001069)
44. Meinl E, Krumbholz M, Derfuss T, Junker A, Hohlfeld R. Compartmentalization of inflammation in the CNS: a major mechanism driving progressive multiple sclerosis. J Neurol Sci 2008; 274: 42-4.
45. Moll NM, Rietsch BS, Ransohoff AJ, Cossoy MB, Huang D, Eichler FS, et al. Cortical demyelination in PML and MS. Neurology 2008; 70: 336.
46. Owens GP, Ritchie AM, Burgoon MP, Williamson RA, Corboy JR, Gilden DH. Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid. J Immunol 2003; 171: 2725-33. (Pubitemid 37025586)
47. Pender MP. Does Epstein-Barr virus infection in the brain drive the development of multiple sclerosis? Brain 2009; 132: 3196-8.
48. Peters A, Palay S, Webster H. The fine structure of the nervous system: neurons and their supporting cells. Oxford University Press Inc, USA; 1991.
49. Peterson JW, Bo L, Mork S, Chang A, Trapp BD. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol 2001; 50: 389-400. (Pubitemid 32848742)
50. Pirko I, Lucchinetti CF, Sriram S, Bakshi R. Gray matter involvement in multiple sclerosis. Neurology 2007; 68: 634-42. (Pubitemid 46667808)
51. Prineas JW. Multiple sclerosis: presence of lymphatic capillaries and lymphoid tissue in the brain and spinal cord. Science 1979; 203: 1123-5. (Pubitemid 9148091)
52. Ransohoff RM. Immunology: in the beginning. Nature 2009; 462: 41-2.
53. Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, et al. Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis. Neurology 2009; 74: 1127-35.
54. Scalfari A, Neuhaus A, Degenhardt A, Rice GP, Muraro PA, Daumer M, et al. The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability. Brain 2010; 133: 1914-29.
55. Schmierer K, Parkes HG, So PW, An SF, Brandner S, Ordidge RJ, et al. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis. Brain 2010; 133: 858-67.
56. Serafini B, Rosicarelli B, Magliozzi R, Stigliano E, Aloisi F. Detection of ectopic B-cell follicles with germinal centers in the meninges of patients with secondary progressive multiple sclerosis. Brain Pathol 2004; 14: 164-74. (Pubitemid 38656388)
57. Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, et al. Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain. J Exp Med 2007; 204: 2899-912. (Pubitemid 350179559)
58. Serafini B, Severa M, Columba-Cabezas S, Rosicarelli B, Veroni C, Chiappetta G, et al. Epstein-Barr virus latent infection and BAFF expression in B cells in the multiple sclerosis brain: implications for viral persistence and intrathecal B-cell activation. J Neuropathol Exp Neurol 2010; 69: 677-93.
59. Shin T, Kojima T, Tanuma N, Ishihara Y, Matsumoto Y. The subarach-noid space as a site for precursor T cell proliferation and effector T cell selection in experimental autoimmune encephalomyelitis. J Neuroimmunol 1995; 56: 171-8.
60. Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med 2004; 350: 1328-37. (Pubitemid 38375368)
61. Torkildsen O, Stansberg C, Angelskar SM, Kooi EJ, Geurts JJ, van der Valk P, et al. Upregulation of immunoglobulin-related genes in cortical sections from multiple sclerosis patients. Brain Pathol 2010; 20: 720-9.
62. Vercellino M, Plano F, Votta B, Mutani R, Giordana MT, Cavalla P. Grey matter pathology in multiple sclerosis. J Neuropathol Exp Neurol 2005; 64: 1101-7.
63. Vercellino M, Merola A, Piacentino C, Votta B, Capello E, Mancardi GL, et al. Altered glutamate reuptake in relapsing-remitting and secondary progressive multiple sclerosis cortex: correlation with microglia infiltration, demyelination, and neuronal and synaptic damage. J Neuropathol Exp Neurol 2007; 66: 732-9. (Pubitemid 47344252)
64. Vukusic S, Confavreux C. Prognostic factors for progression of disability in the secondary progressive phase of multiple sclerosis. J Neurol Sci 2003; 206: 135-7. (Pubitemid 36143717)
65. Wegner C, Esiri MM, Chance SA, Palace J, Matthews PM. Neocortical neuronal, synaptic, and glial loss in multiple sclerosis. Neurology 2006; 67: 960-7. (Pubitemid 44454585)
66. Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, et al. Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain. Brain 2009; 132: 3318-28.
67. Zeis T, Graumann U, Reynolds R, Schaeren-Wiemers N. Normal-appearing white matter in multiple sclerosis is in a subtle balance between inflammation and neuroprotection. Brain 2008; 131: 288-303.
68. Zhang ET, Inman CB, Weller RO. Interrelationships of the pia mater and the perivascular (Virchow-Robin) spaces in the human cerebrum. J Anat 1990; 170: 111-23. (Pubitemid 20209323)
69. Zhang ET, Richards HK, Kida S, Weller RO. Directional and compartmentalised drainage of interstitial fluid and cerebrospinal fluid from the rat brain. Acta Neuropathol 1992; 83: 233-9.
70. Zivadinov R, Zorzon M, Weinstock-Guttman B, Serafin M, Bosco A, Bratina A, et al. Epstein-Barr virus is associated with grey matter atrophy in multiple sclerosis. J Neurol Neurosurg Psychiatry 2009; 80: 620-5.